Welcome to our dedicated page for Aveanna Healthcare Holdings SEC filings (Ticker: AVAH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aveanna Healthcare Holdings Inc. (AVAH) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Aveanna, a diversified home care platform headquartered in Atlanta, Georgia with locations in 38 states, uses these filings to report material events, financing arrangements, and financial results related to its pediatric and adult home-based healthcare services.
Among the key documents available are Current Reports on Form 8-K, where Aveanna describes material definitive agreements such as amendments to its first lien credit agreement, the creation and refinancing of term loan and revolving credit facilities, and the termination of a second lien credit agreement. Other 8-K filings report underwriting agreements for secondary offerings of common stock by existing stockholders, as well as the closing of those offerings.
Aveanna also uses Form 8-K to furnish press releases announcing quarterly and year-to-date financial results, preliminary financial data, and updated guidance. These filings often discuss non-GAAP measures such as EBITDA, Adjusted EBITDA, Normalized Adjusted EBITDA, Field contribution, Field contribution margin, Adjusted net income, and Adjusted net income per diluted share, along with reconciliations to GAAP metrics. Additional 8-K items address board and governance matters, including amendments to stockholders’ agreements and changes in board composition.
On Stock Titan, users can view these AVAH filings alongside AI-powered summaries that explain the main points of each document in plain language. Real-time updates from EDGAR help surface new 8-Ks and, when filed, periodic reports such as annual reports on Form 10-K, quarterly reports on Form 10-Q, and proxy statements. The platform also highlights insider-related filings like Form 4 when available, allowing investors to review reported transactions by directors and officers in the context of Aveanna’s broader regulatory and financial disclosures.
Aveanna Healthcare Holdings Inc. furnished a March 2026 investor presentation outlining recent performance, capital structure and long‑term growth plans. For Q4 2025, revenue rose from $519.9m to $662.5m, a 27.4% increase, while gross margin grew from $171.7m to $213.3m. Adjusted EBITDA increased from $55.2m to $85.0m, up 54.0%. For full‑year 2025, operating cash flow was $125.9m and free cash flow was $131.0m. The company guided 2026 revenue to $2.54b–$2.56b with Adjusted EBITDA of $318m–$322m, supported by a national platform of 366 locations in 38 states and 29,000 caregivers. Liquidity totaled $528.8m, against $1,487m of variable‑rate debt, partially hedged with swaps and caps. Aveanna highlights value‑based growth across Private Duty Services, Home Health & Hospice, and Medical Solutions, each with targeted organic growth and margin ranges.
Aveanna Healthcare Holdings Inc. files its annual report describing a large, diversified home care platform focused on medically complex, high‑cost patients treated at home. The company operates across three segments—Private Duty Services, Home Health & Hospice, and Medical Solutions—serving multiple age groups in 38 states.
Aveanna highlights scale advantages, dense local networks, and extensive technology investments in recruiting, scheduling, electronic medical records, and revenue cycle tools. It reports more than 1,500 distinct payers, substantial Medicaid and Medicare exposure, and emphasizes value‑based care, acquisitions (18 since 2017), and a strong compliance culture.
Aveanna Healthcare reported strong growth for the quarter and fiscal year ended January 3, 2026. Fourth quarter revenue was $662.5 million, up 27.4% from the prior year, with net income of $178.8 million versus $29.2 million. Adjusted EBITDA rose to $85.0 million, a 54.0% increase.
For 2025, revenue reached $2,433.2 million, up 20.2%, and the company swung to full-year net income of $225.0 million from a $10.9 million loss. Full-year Adjusted EBITDA grew to $320.9 million, up 74.8%. Management reaffirmed 2026 guidance for revenue of $2.54–$2.56 billion and Adjusted EBITDA of $318–$322 million.
Aveanna also agreed to acquire Family First Homecare for $175.5 million, expected to close in the second fiscal quarter of 2026, expanding its pediatric home care footprint. As of January 3, 2026, the company had cash of $193.3 million, free cash flow of $131.0 million for 2025, and total indebtedness of $1,486.7 million.
Aveanna Healthcare Holdings, Inc. director Samuel Altman has filed an initial Form 3 statement of beneficial ownership. The excerpt lists him as a director of the company and shows no reported buy, sell, or other share transactions in this filing data.
Aveanna Healthcare Holdings Inc. is expanding its pediatric home care network by agreeing to acquire Family First Holding, LLC for a cash purchase price of $175.5 million, subject to customary adjustments. Aveanna plans to fund the deal with cash on hand and existing short-term credit facility borrowings.
Family First Homecare is a multi-state pediatric home care provider with 27 locations across seven states, focused on skilled Private Duty Nursing. The transaction is expected to close in Aveanna’s second fiscal quarter of 2026, subject to Hart-Scott-Rodino clearance, customary closing conditions, and the absence of a material adverse effect.
Aveanna Healthcare Holdings Inc. reported that Robert M. Williams, Jr. has resigned from its Board of Directors effective February 27, 2026. He had served as a Class I director and was a member of the Nominating and Corporate Governance, Compensation, and Clinical Quality and Compliance Committees.
The company stated that Mr. Williams’ decision to resign was not due to any disagreement with Aveanna regarding its operations, policies, or practices. The filing is signed by Chief Executive Officer Jeff Shaner.
Aveanna Healthcare Holdings Inc. updated employment agreements for its President and CEO Jeff Shaner, CFO Matthew Buckhalter, and Chief Legal Officer Jerry Perchik through its Aveanna Healthcare, LLC subsidiary. The new contracts set minimum annual base salaries of $750,000 for Shaner, $500,000 for Buckhalter, and $450,000 for Perchik, with target annual bonuses equal to 100%, 75%, and 75% of salary, respectively, plus eligibility for discretionary equity awards under the 2021 Stock Incentive Plan.
If terminated without cause or resigning for good reason outside a change in control, Shaner is eligible for cash severance equal to 2x salary plus target bonus, while Buckhalter and Perchik receive 1x, along with pro‑rated bonuses, partial vesting of equity, and subsidized COBRA for up to 24 months for Shaner and 12 months for the others. During a defined change in control period, severance rises to 2.5x salary plus target bonus for Shaner and 2x for the others, full vesting of equity based on actual or target performance, and COBRA-related cash or subsidies for 30 months for Shaner and 24 months for the others. All severance requires a signed release and continued compliance with non‑competition, non‑solicitation, non‑disparagement, and confidentiality covenants.
Aveanna Healthcare Holdings Chief Executive Officer Jeff Shaner reported tax-related stock sales. Over February 17–19, 2026, he sold a total of 461,909 shares of common stock in open-market transactions at weighted average prices between about $7.06 and $7.97. According to the footnotes, these sales were automatically executed by the company’s stock plan administrator to cover his tax obligations arising from vested equity awards. After these sales, Shaner directly held 2,650,892 shares of Aveanna common stock.
Aveanna Healthcare Holdings, Inc. Chief Compliance Officer Patrick A. Cunningham reported automatic sales of common stock to cover taxes on vested equity awards. Over February 17–19, 2026, he sold a total of 49,160 shares in open-market transactions at weighted average prices ranging from $7.06 to $7.97 per share, as part of aggregate sales handled by the company’s stock plan administrator. Following these sales, he directly holds 337,755 shares of Aveanna common stock.
Aveanna Healthcare Holdings, Inc. Chief Financial Officer Matthew Buckhalter reported open-market sales of a total of 36,030 shares of common stock over three days. The sales occurred on February 17, 18, and 19, 2026 at weighted average prices of $7.6451, $7.3829, and $7.2082 per share, respectively.
According to the footnotes, these shares were automatically sold to satisfy the reporting person’s tax obligations arising from shares issued upon vesting of equity awards and were executed as part of aggregate sales by the company’s stock plan administrator. After these transactions, Buckhalter directly owns 529,243 shares of Aveanna common stock.